JF
STRO icon

Jump Financial’s Sutro Biopharma STRO Stock Holding History

Jump Financial’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,385
Closed -$309K – 2445
2026
Q1 		$309K Buy
+12,385
New +$224K ﹤0.01% 1469
2024
Q2 		– Sell
-11,120
Closed -$628K – 2239
2024
Q1 		$628K Buy
+11,120
New +$491K 0.02% 1054
2023
Q1 		– Sell
-4,260
Closed -$344K – 2043
2022
Q4 		$344K Sell
4,260
-330
-7% -$22.9K 0.02% 962
2022
Q3 		$255K Buy
+4,590
New +$272K 0.01% 1227
2022
Q2 		– Sell
-3,280
Closed -$270K – 2005
2022
Q1 		$270K Buy
+3,280
New +$312K 0.01% 1126
2021
Q1 		– Sell
-2,069
Closed -$449K – 1264
2020
Q4 		$449K Buy
+2,069
New +$343K 0.08% 415

Other funds holding STRO

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Jump Financial's STRO Position: Q2 2026 in Review

Jump Financial sold out of Sutro Biopharma (STRO) in Q2 2026, closing a stake of 12,385 shares — an estimated $309K sold.

Jump Financial first reported a position in STRO in Q4 2020 and held it in 6 quarters. The position peaked at $628K in Q1 2024. 100 funds tracked by Wall St. Rank hold STRO as of Q2 2026.

  • Jump Financial reported no remaining Sutro Biopharma position as of Q2 2026 after selling out during the quarter.
  • Jump Financial sold 12,385 Sutro Biopharma shares in Q2 2026, an estimated $309K.
  • Jump Financial first reported a position in Sutro Biopharma in Q4 2020 and held it in 6 quarters.
  • Jump Financial's Sutro Biopharma position peaked at $628K in Q1 2024.
  • 100 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.